Respiratory Syncytial Virus RSV Therapeutics Industry
Date: Aug-2021 | Id: MACRC-73079 | Geographical Scope: Global
The global Respiratory Syncytial Virus (RSV) Therapeutics market was valued at 546.06 Million USD in 2020 and will grow with a CAGR of 5.76% from 2020 to 2027, based on Mnemonics Research newly published report. The prime objective of this repor...